Life Sciences & Healthcare

Salter Group’s dedicated Life Sciences & Health Care team possesses an in-depth knowledge of the life sciences industry. A distinguishing feature of our Life Sciences & Health Care experience is our ability to effectively understand and communicate the value proposition for a product across its life cycle for financing, licensing and M&A transactions. We integrate advanced patient flow and financial modeling techniques and robust data-driven research to develop credible forecasts that serve as a foundation for a valuation discussion. For certain transactions, we use simulation capabilities to develop probability based forecasts which assist to better understand prospective license and deal structures. We leverage our understanding of industry to provide accounting and tax related services to life sciences companies, in some instances, leveraging our work for multiple purposes.

Since 2009, Salter Group has completed over 100 life sciences and health care engagements representing over $7 billion in asset and transaction values. Salter Group is a partner member of BayBio.

Industry sectors that we have served include:

• Therapeutics
• Diagnostics
• Medical Devices
• Research Equipment and Tools
• Contract Service Organizations
• Healthcare Services Organizations